News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
ADC drug market hits $20B, packaging complexity forces pharma to hire specialists
23 approved antibody-drug conjugates globally; 412 more in trials. Potent payloads demand high-containment handling, small batch flexibility, and multi-country launch readiness—here's why packaging partners are now critical to speed.
Community cancer trial enrollment jumps 6.5x with EHR automation
A pilot study at four US oncology centers enrolled patients 6.5 times faster and cut costs 20-30% using automated EHR-to-EDC data capture. Black and Hispanic representation hit 30.5% — more than double typical myeloma trials.
Moderna's flu vaccine wins unanimous FDA panel vote, clears path to August decision
Moderna's mRNA-1010 flu vaccine passed FDA advisory committee 9-0 on June 18, showing 26.6% higher effectiveness than standard shots. The company faces an August 5, 2026 decision deadline.
Pharma Shifts to Patient Adherence Tech at HLTH Europe 2026
At HLTH Europe 2026 in Amsterdam, pharma and medtech leaders outlined what adherence-focused tools must do: be flexible, engaging, adaptable and affordable. Early deployments focus on AI-driven outreach and at-home sensors.
Eight gene therapies now cost $2.8M to $4.25M per patient
Gene therapies for rare genetic diseases are now priced between $2.8 million and $4.25 million in the U.S., with Orchard's Lenmeldy topping the list. Here's what drives these costs and which diseases they treat.
One Breast Milk Fatty Acid Shapes Immune Response Into Adulthood
University of Chicago researchers found trans-vaccenic acid in breast milk reprograms infant immune cells, boosting pathogen response for life. The discovery points to a single nutrient's outsized role in neonatal development.
Immune Cells in Brain Drive Autism Social Deficits in Mouse Model
Researchers found γδ T cells infiltrating the brains of mice with a genetic autism model, reducing sociability. Removing these cells restored social behavior, pointing to immune dysregulation as a treatment target.
Sanofi and Roche back Orano Med's rare cancer isotope play
Orano Med secured backing from two pharma giants to commercialize lead-212, a rare alpha emitter for oncology. Here's why supply control matters for radioimmunotherapy.
Pfizer CFO Dave Denton exits for consumer goods role
Dave Denton, who joined Pfizer's finance leadership in 2022 from Lowe's, is leaving for an unspecified opportunity in consumer goods. The departure marks another shift in Pfizer's C-suite.
12-Week Yoga Program Lifted Cognition Scores in Alzheimer's Patients, AIIMS Study Finds
AIIMS researchers tracked 60-minute daily yoga sessions in mild Alzheimer's patients and saw improvements in Montreal Cognitive Assessment scores, reduced depression, and shifts toward healthier gut bacteria. The catch: no control group and small sample size.
FSSAI flags 'natural' and 'healthy' labels on 50+ food products
India's food regulator is cracking down on misleading health claims, issuing notices to brands selling mango juice as 'no added sugar' despite 49% sugarcane content. What counts as false advertising under existing rules.
India's AYUSH Secretary gets fifth extension through June 2027
Vaidya Rajesh Kotecha, who led India's traditional medicine ministry since 2017, receives his fifth tenure extension. The decision signals continuity in AYUSH policy direction.